Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Kamada ( (IL:KMDA) ) just unveiled an announcement.
On March 24, 2025, Kamada Ltd. announced a tax ruling from the Israel Tax Authority regarding a special cash dividend of $0.20 per share, totaling approximately $11.5 million, to be paid on April 7, 2025. The ruling allows Nasdaq Shareholders from countries with tax treaties with Israel to potentially benefit from a reduced withholding tax rate. Kamada has appointed IBI Trust Management as a processing agent to facilitate this process. Shareholders are advised to consult their tax advisors for specific tax implications.
More about Kamada
Kamada Ltd. is a global biopharmaceutical company specializing in specialty plasma-derived therapies. The company focuses on treating rare and serious conditions and aims to drive profitable growth through organic growth from its commercial activities, including the commercialization and life cycle management of its proprietary products, which include six FDA-approved specialty plasma-derived products.
YTD Price Performance: 13.51%
Average Trading Volume: 227,704
Technical Sentiment Signal: Sell
Current Market Cap: $380.7M
See more data about KMDA stock on TipRanks’ Stock Analysis page.